Inventor · disambiguated record
Hwai Wen Chang
Also filed as: CHANG HWAI · CHANG HWAI W · CHANG HWAI WEN
56 granted patents·37 pending applications·576 citations·filing 1997–2025
98Inventor score
Top patents by PatentIndex Score
93 records- 0199US9683048B2Antibody molecules to PD-1 and uses thereofNOVARTIS AG·Filed 2015·Granted Jun 20, 2017·115 cites·144 claims
- 0298US10711060B2Antibody molecules to LAG-3 and uses thereofNOVARTIS AG·Filed 2017·Granted Jul 14, 2020·29 cites·5 claims
- 0398US9815898B2Antibody molecules to PD-1 and uses thereofNOVARTIS AG·Filed 2017·Granted Nov 14, 2017·35 cites·30 claims
- 0497US10851165B2Antibody molecules to PD-L1 and methods of treating cancerNOVARTIS AG·Filed 2018·Granted Dec 1, 2020·10 cites·80 claims
- 0597US10259873B2Therapeutic CD47 antibodiesARCH ONCOLOGY INC·Filed 2016·Granted Apr 16, 2019·21 cites·4 claims
- 0697US9988452B2Antibody molecules to PD-L1 and uses thereofNOVARTIS AG·Filed 2015·Granted Jun 5, 2018·30 cites·27 claims
- 0797US9518117B2Therapeutic CD47 antibodiesVASCULOX INC·Filed 2015·Granted Dec 13, 2016·23 cites·6 claims
- 0897US9518116B2Therapeutic CD47 antibodiesVASCULOX INC·Filed 2015·Granted Dec 13, 2016·27 cites·9 claims
- 0997US9221908B2Therapeutic CD47 antibodiesVASCULOX INC·Filed 2013·Granted Dec 29, 2015·46 cites·5 claims
- 1097US8709755B2Mirac proteinsSHORT JAY M·Filed 2012·Granted Apr 29, 2014·38 cites·3 claims
- 1196US11773509B2Conditionally active polypeptides and methods of generating themBIOATLA INC·Filed 2021·Granted Oct 3, 2023·2 cites·19 claims
- 1296US10752687B2Antibody molecules to PD-1 and uses thereofNOVARTIS AG·Filed 2017·Granted Aug 25, 2020·6 cites·90 claims
- 1396US9908936B2Antibody molecules to LAG-3 and uses thereofNOVARTIS AG·Filed 2017·Granted Mar 6, 2018·23 cites·30 claims
- 1496US8062866B2Humanized anti-IL-6 antibodiesFREY GERHARD·Filed 2009·Granted Nov 22, 2011·49 cites·24 claims
- 1595US11897959B2Anti-AXL antibodies, antibody fragments and their immunoconjugates and uses thereofBIOATLA INC·Filed 2021·Granted Feb 13, 2024·2 cites·20 claims
- 1695US11111288B2Conditionally active chimeric antigen receptors for modified t-cellsBIOATLA LLC·Filed 2018·Granted Sep 7, 2021·9 cites·23 claims
- 1794US11827704B2Antibody molecules to PD-1 and uses thereofNOVARTIS AG·Filed 2020·Granted Nov 28, 2023·2 cites·43 claims
- 1894US10822426B2Humanized anti-CD73 antibodiesCORVUS PHARMACEUTICALS INC·Filed 2016·Granted Nov 3, 2020·11 cites·27 claims
- 1993US12110611B2Conditionally active biological proteinsBIOATLA INC·Filed 2022·Granted Oct 8, 2024·1 cites·8 claims
- 2093US11851499B2Conditionally active anti-EpCAM antibodies, antibody fragments, their immunoconjugates and uses thereofBIOATLA INC·Filed 2020·Granted Dec 26, 2023·2 cites·27 claims
- 2193US8043839B2Xylanases, nucleic acids encoding them and methods for making and using themVERENIUM CORP·Filed 2007·Granted Oct 25, 2011·27 cites·6 claims
- 2291US11472876B2Conditionally active polypeptidesBIOATLA INC·Filed 2016·Granted Oct 18, 2022·4 cites·11 claims
- 2391US11279924B2Conditionally active polypeptides and methods of generating themBIOATLA LLC·Filed 2017·Granted Mar 22, 2022·3 cites·21 claims
- 2491US11254932B2Conditionally active biological proteinsBIOATLA LLC·Filed 2020·Granted Feb 22, 2022·2 cites·32 claims
- 2590US10669336B2Therapeutic CD47 antibodiesARCH ONCOLOGY INC·Filed 2017·Granted Jun 2, 2020·4 cites·2 claims
- 2690US2025066479A1Antibody molecules to pd-1 and uses thereofNOVARTIS AG·Filed 2024·Application pending·0 cites
- 2789US11149088B2Anti-Axl antibodies, antibody fragments and their immunoconjugates and uses thereofBIOATLA LLC·Filed 2017·Granted Oct 19, 2021·3 cites·6 claims
- 2889US2023332135A1Mirac proteinsBIOATLA INC·Filed 2023·Application pending·0 cites
- 2988US2024417886A1Conditionally active biological proteinsBIOATLA INC·Filed 2024·Application pending·0 cites
- 3087US12311032B2Anti-Ror2 antibodies, antibody fragments, their immunoconjugates and uses thereofBIOATLA INC·Filed 2023·Granted May 27, 2025·0 cites·24 claims
- 3187US9856323B2Anti-CD22 antibodiesBIOATLA LLC·Filed 2013·Granted Jan 2, 2018·10 cites·22 claims
- 3286US11413340B2Mesothelin chimeric antigen receptor (CAR) and antibody against PD-L1 inhibitor for combined use in anticancer therapyNOVARTIS AG·Filed 2016·Granted Aug 16, 2022·2 cites·32 claims
- 3386US9637734B2Mirac proteinsBIOATLA LLC·Filed 2014·Granted May 2, 2017·5 cites·30 claims
- 3486US2024343808A1Antibody molecules to pg-l1 and methods of treating cancer and infectious diseasesNOVARTIS AG·Filed 2023·Application pending·0 cites
- 3585US12427347B2Conditionally active anti-EpCAM antibodies, antibody fragments, their immunoconjugates and uses thereofBIOATLA INC·Filed 2023·Granted Sep 30, 2025·0 cites·18 claims
- 3685US11718844B2Mirac proteinsBIOATLA INC·Filed 2017·Granted Aug 8, 2023·1 cites·18 claims
- 3785US10676524B2Therapeutic CD47 antibodiesARCH ONCOLOGY INC·Filed 2017·Granted Jun 9, 2020·2 cites·4 claims
- 3883US11254742B2Anti-Ror2 antibodies, antibody fragments, their immunoconjugates and uses thereofBIOATLA LLC·Filed 2017·Granted Feb 22, 2022·1 cites·34 claims
- 3982US2023374702A1Method for preparing a conditionally active antibody or antibody fragmentBIOATLA INC·Filed 2023·Application pending·0 cites
- 4081US10696750B2Multi-specific monoclonal antibodiesBIOATLA LLC·Filed 2019·Granted Jun 30, 2020·1 cites·20 claims
- 4181US9556413B2System and methods for anaerobic environmental microbial compartmentalized cultivationVENTER J CRAIG·Filed 2008·Granted Jan 31, 2017·8 cites·10 claims
- 4281US9464284B2Mirac proteinsSHORT JAY M·Filed 2010·Granted Oct 11, 2016·3 cites·31 claims
- 4381USRE45660EXylanases, nucleic acids encoding them and methods for making and using themBP CORP NORTH AMERICA INC·Filed 2007·Granted Sep 1, 2015·3 cites·6 claims
- 4481US2023192849A1Therapeutic cd47 antibodiesARCH ONCOLOGY INC·Filed 2022·Application pending·0 cites
- 4580US9637735B2Mirac proteinsBIOATLA LLC·Filed 2014·Granted May 2, 2017·2 cites·31 claims
- 4680US2024199746A1Anti-axl antibodies, antibody fragments and their immunoconjugates and uses thereofBIOATLA INC·Filed 2024·Application pending·0 cites
- 4779US10329556B2Conditionally active biological proteinsBIOATLA LLC·Filed 2015·Granted Jun 25, 2019·2 cites·13 claims
- 4878US11879011B2Anti-ROR2 antibodies, antibody fragments, their immunoconjucates and uses thereofBIOATLA INC·Filed 2021·Granted Jan 23, 2024·0 cites·24 claims
- 4978US11542332B2Anti-CTLA4 antibodies, antibody fragments, their immunoconjugates and uses thereofBIOATLA INC·Filed 2019·Granted Jan 3, 2023·1 cites·19 claims
- 5078US9994841B2Mirac proteinsBIOATLA LLC·Filed 2016·Granted Jun 12, 2018·1 cites·32 claims
Showing the top 50 of 93 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Hwai Wen Chang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →